Prostaglandin E1 Agonist [EPC]

Prostaglandin E1 Agonist [EPC] was reported 3625 times

Drugs of the Prostaglandin E1 Agonist [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 INFANTILE CORTICAL HYPEROSTOSIS 11 0.5000
1 HARLEQUIN SKIN REACTION 5 0.3333
2 PENIS DEVIATION 4 0.1111
3 CARTILAGE HYPERTROPHY 2 0.1000
4 NEONATAL APNOEIC ATTACK 6 0.0741
5 CAPILLARY FRAGILITY INCREASED 2 0.0690
6 PAINFUL ERECTION 47 0.0682
7 PENILE CURVATURE 16 0.0681
8 INFANTILE APNOEIC ATTACK 14 0.0598
9 ARTERIOSCLEROSIS OBLITERANS 4 0.0494
10 FEVER NEONATAL 6 0.0458
11 PEYRONIE'S DISEASE 8 0.0442
12 PENILE BURNING SENSATION 12 0.0423
13 BASE EXCESS NEGATIVE 2 0.0377
14 SCLEREMA 3 0.0370
15 INCISION SITE PAIN 43 0.0366
16 RED BLOOD CELLS URINE POSITIVE 33 0.0341
17 ARM AMPUTATION 6 0.0330
18 NEONATAL HYPONATRAEMIA 4 0.0328
19 ERECTION INCREASED 136 0.0325
20 PENILE DISCOMFORT 4 0.0310
21 MUCOCUTANEOUS ULCERATION 7 0.0308
22 ENDOTOXIC SHOCK 2 0.0290
23 PENILE PAIN 88 0.0289
24 CARDIAC SEPTAL HYPERTROPHY 8 0.0289
25 THROMBOANGIITIS OBLITERANS 3 0.0288
26 PENIS INJURY 10 0.0278
27 PENILE NECROSIS 3 0.0270
28 APNOEIC ATTACK 14 0.0248
29 COMPUTERISED TOMOGRAM HEART ABNORMAL 2 0.0244
30 BASILAR ARTERY OCCLUSION 4 0.0241
31 PRIAPISM 81 0.0235
32 PENILE HAEMORRHAGE 19 0.0233
33 VESSEL PUNCTURE SITE HAEMATOMA 4 0.0203
34 INFANTILE APNOEA 16 0.0196
35 BALANITIS 2 0.0164
36 SYSTOLIC HYPERTENSION 7 0.0162
37 PENIS DISORDER 38 0.0153
38 CARDIAC ARREST NEONATAL 2 0.0145
39 SHUNT STENOSIS 4 0.0144
40 PENILE SWELLING 17 0.0139
41 URETHRAL HAEMORRHAGE 8 0.0132
42 LOWER RESPIRATORY TRACT INFECTION FUNGAL 5 0.0129
43 PENILE SIZE REDUCED 12 0.0126
44 BONE HYPERTROPHY 2 0.0124
45 PROSTATECTOMY 7 0.0122
46 PERIOSTITIS 5 0.0116
47 DELAYED GRAFT FUNCTION 8 0.0113
48 PULMONARY HYPERTENSIVE CRISIS 3 0.0111
49 ANTITHROMBIN III DECREASED 3 0.0110
50 PENILE CONTUSION 5 0.0104
51 PROSTATIC OPERATION 12 0.0100
52 NEONATAL HYPOXIA 8 0.0097
53 HEPATECTOMY 3 0.0096
54 PENILE ULCERATION 3 0.0092
55 WRONG STRENGTH 3 0.0091
56 CONGENITAL PULMONARY VALVE ATRESIA 2 0.0090
57 ENDOTHELIAL DYSFUNCTION 2 0.0086
58 TONGUE INJURY 8 0.0085
59 URETHRAL PAIN 5 0.0085
60 FAT EMBOLISM 3 0.0085
61 VASCULITIS NECROTISING 6 0.0084
62 NEONATAL HYPOTENSION 3 0.0082
63 GASTRIC MUCOSAL HYPERTROPHY 2 0.0081
64 PENILE ERYTHEMA 3 0.0080
65 CYSTITIS VIRAL 3 0.0078
66 CONVULSION NEONATAL 4 0.0076
67 INCISION SITE IMPAIRED HEALING 3 0.0074
68 CYTOMEGALOVIRUS VIRAEMIA 33 0.0074
69 ILIAC ARTERY OCCLUSION 2 0.0073
70 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 10 0.0071
71 COMPLICATIONS OF TRANSPLANTED KIDNEY 16 0.0070
72 GENITAL PARAESTHESIA 2 0.0069
73 FOREIGN BODY TRAUMA 5 0.0068
74 CYANOPSIA 4 0.0067
75 CAPILLARY LEAK SYNDROME 13 0.0063
76 PO2 DECREASED 7 0.0061
77 PROTEIN URINE PRESENT 30 0.0060
78 EXPOSURE VIA PARTNER 3 0.0060
79 BILIRUBIN CONJUGATED INCREASED 13 0.0056
80 SCROTAL PAIN 3 0.0056
81 TRANSIENT GLOBAL AMNESIA 4 0.0055
82 NEUTROPHIL COUNT INCREASED 54 0.0053
83 CYSTITIS HAEMORRHAGIC 21 0.0052
84 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0051
85 URETERIC STENOSIS 4 0.0050
86 GRANULOCYTE COUNT INCREASED 2 0.0049
87 DUCTUS ARTERIOSUS PREMATURE CLOSURE 2 0.0049
88 AMPUTATION 6 0.0048
89 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 5 0.0047
90 GENITAL BURNING SENSATION 4 0.0046
91 CARDIAC OUTPUT DECREASED 4 0.0045
92 LYMPHOCYTE COUNT DECREASED 79 0.0045
93 FEEDING INTOLERANCE 2 0.0044
94 TESTICULAR PAIN 14 0.0044
95 URETHRAL STENOSIS 3 0.0044
96 HYPOPROTEINAEMIA 8 0.0042
97 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
98 PHIMOSIS 3 0.0041
99 PULMONARY HYPOPLASIA 3 0.0038
100 FRACTURE OF PENIS 2 0.0038
101 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
102 HYPERAMYLASAEMIA 2 0.0037
103 ERECTILE DYSFUNCTION 93 0.0036
104 BLOOD PH INCREASED 2 0.0036
105 PULMONARY SARCOIDOSIS 4 0.0036
106 KIDNEY TRANSPLANT REJECTION 17 0.0035
107 BLOOD UREA INCREASED 59 0.0035
108 BLOOD OESTROGEN INCREASED 2 0.0034
109 BLOOD ALBUMIN INCREASED 3 0.0034
110 MUSCLE SWELLING 3 0.0033
111 BLOOD BILIRUBIN DECREASED 2 0.0032
112 NEONATAL DISORDER 5 0.0032
113 OBSTRUCTION GASTRIC 4 0.0031
114 CONTINUOUS HAEMODIAFILTRATION 3 0.0031
115 HIGH DENSITY LIPOPROTEIN INCREASED 3 0.0030
116 HIGH DENSITY LIPOPROTEIN DECREASED 10 0.0030
117 TESTICULAR DISORDER 3 0.0030
118 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
119 GASTROINTESTINAL INFECTION 26 0.0029
120 NECROSIS 16 0.0029
121 SYSTOLIC DYSFUNCTION 3 0.0028
122 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
123 CEREBRAL VASOCONSTRICTION 2 0.0027
124 EPSTEIN-BARR VIRAEMIA 3 0.0027
125 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
126 KLEBSIELLA SEPSIS 3 0.0027
127 BLOOD ALBUMIN DECREASED 21 0.0026
128 ACUTE GRAFT VERSUS HOST DISEASE 12 0.0026
129 THERAPEUTIC PRODUCT EFFECT INCREASED 3 0.0026
130 PATENT DUCTUS ARTERIOSUS 10 0.0025
131 EJACULATION FAILURE 5 0.0025
132 BARRETT'S OESOPHAGUS 2 0.0025
133 INCISION SITE HAEMORRHAGE 2 0.0025
134 APNOEA 19 0.0024
135 ACCIDENTAL NEEDLE STICK 2 0.0024
136 TESTICULAR SWELLING 3 0.0024
137 NECROTISING COLITIS 3 0.0024
138 CAROTID ARTERY THROMBOSIS 2 0.0024
139 POSTOPERATIVE WOUND COMPLICATION 3 0.0024
140 CRANIOFACIAL FRACTURE 2 0.0023
141 APGAR SCORE LOW 3 0.0023
142 LIBIDO DISORDER 3 0.0023
143 ARTERIAL STENOSIS 2 0.0023
144 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
145 EXPIRED DRUG ADMINISTERED 11 0.0022
146 URETERIC OBSTRUCTION 3 0.0022
147 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
148 HAEMATOTOXICITY 20 0.0021
149 GENITAL RASH 3 0.0021
150 VASCULAR INJURY 3 0.0021
151 BLOOD URINE 2 0.0021
152 ANAL CANCER 2 0.0021
153 HEPATIC FIBROSIS 7 0.0020
154 PNEUMONIA STAPHYLOCOCCAL 4 0.0020
155 PERIPHERAL ISCHAEMIA 8 0.0020
156 FACIAL BONES FRACTURE 7 0.0019
157 LEG AMPUTATION 8 0.0019
158 CAROTID ARTERIOSCLEROSIS 2 0.0019
159 ENTEROCOLITIS 11 0.0019
160 DEVICE INEFFECTIVE 2 0.0019
161 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 4 0.0018
162 PARESIS 4 0.0018
163 ENTEROBACTER INFECTION 3 0.0018
164 BK VIRUS INFECTION 6 0.0018
165 DEVICE FAILURE 27 0.0018
166 NEUROPATHY 3 0.0018
167 BLOODY DISCHARGE 2 0.0017
168 WOUND COMPLICATION 6 0.0017
169 INCORRECT STORAGE OF DRUG 3 0.0017
170 NEPHROGENIC ANAEMIA 8 0.0017
171 EPIDIDYMITIS 2 0.0017
172 PSEUDOMONAL SEPSIS 3 0.0017
173 HYPERURICAEMIA 7 0.0017
174 NEEDLE ISSUE 49 0.0017
175 CHRONIC GRAFT VERSUS HOST DISEASE 6 0.0017
176 GANGRENE 10 0.0017
177 CEREBRAL ARTERY EMBOLISM 2 0.0016
178 VIRAL MUTATION IDENTIFIED 6 0.0016
179 PUPILLARY REFLEX IMPAIRED 3 0.0016
180 BLOOD CHOLESTEROL DECREASED 3 0.0016
181 ANGIOPATHY 9 0.0016
182 BLOOD CREATININE DECREASED 5 0.0016
183 HYPERPARATHYROIDISM SECONDARY 4 0.0016
184 VENTRICULAR HYPERTROPHY 4 0.0016
185 BRADYCARDIA NEONATAL 2 0.0016
186 PRODUCT SOLUBILITY ABNORMAL 8 0.0016
187 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
188 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 2 0.0016
189 TRAUMATIC LUNG INJURY 3 0.0016
190 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
191 PORTAL VEIN THROMBOSIS 5 0.0015
192 SKIN NECROSIS 8 0.0015
193 ASPERGILLOSIS 2 0.0015
194 ISCHAEMIA 7 0.0015
195 EXFOLIATIVE RASH 4 0.0015
196 ARTERIOSPASM CORONARY 6 0.0015
197 DISSEMINATED INTRAVASCULAR COAGULATION 21 0.0015
198 ARTERIOSCLEROSIS 14 0.0015
199 ANORGASMIA 4 0.0015
200 GENERALISED OEDEMA 18 0.0015
201 DILATATION VENTRICULAR 3 0.0014
202 ACUTE PULMONARY OEDEMA 8 0.0014
203 DEVICE CONNECTION ISSUE 3 0.0014
204 LOW DENSITY LIPOPROTEIN INCREASED 11 0.0014
205 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
206 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
207 HEPATIC NEOPLASM MALIGNANT 3 0.0014
208 LUNG INFECTION 22 0.0014
209 HYPOALBUMINAEMIA 11 0.0014
210 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 36 0.0014
211 POOR QUALITY DRUG ADMINISTERED 9 0.0014
212 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
213 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
214 DRUG EFFECT DECREASED 73 0.0014
215 GENITAL PAIN 2 0.0014
216 WHITE BLOOD CELL COUNT INCREASED 51 0.0013
217 PROSTATITIS 4 0.0013
218 SYRINGE ISSUE 23 0.0013
219 CAESAREAN SECTION 15 0.0013
220 PROSTATIC DISORDER 7 0.0013
221 DRUG EFFECT INCREASED 4 0.0013
222 INJECTION SITE INJURY 7 0.0013
223 HYPERLIPIDAEMIA 15 0.0013
224 FOREIGN BODY 5 0.0012
225 MACULAR OEDEMA 7 0.0012
226 AORTIC VALVE DISEASE 2 0.0012
227 PANNICULITIS 3 0.0012
228 ACUTE LEUKAEMIA 2 0.0012
229 COLONIC POLYP 2 0.0012
230 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
231 VENOOCCLUSIVE DISEASE 3 0.0012
232 BLADDER CANCER STAGE IV 2 0.0012
233 SEXUAL DYSFUNCTION 14 0.0012
234 HEPATORENAL SYNDROME 2 0.0012
235 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
236 TOE AMPUTATION 6 0.0012
237 PROTHROMBIN TIME PROLONGED 7 0.0012
238 BLOOD TESTOSTERONE DECREASED 8 0.0012
239 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
240 BLOOD CHLORIDE INCREASED 2 0.0012
241 VENTRICULAR DYSFUNCTION 3 0.0012
242 MUCORMYCOSIS 3 0.0012
243 EXTREMITY NECROSIS 2 0.0011
244 MYOCARDIAL ISCHAEMIA 13 0.0011
245 BLOOD CREATINE INCREASED 5 0.0011
246 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
247 FOREIGN BODY IN REPRODUCTIVE TRACT 10 0.0011
248 PROCEDURAL PAIN 31 0.0011
249 BLOOD SODIUM INCREASED 3 0.0011
250 INJURY ASSOCIATED WITH DEVICE 22 0.0011
251 HAEMODIALYSIS 9 0.0011
252 PARAPLEGIA 3 0.0010
253 ARTERIAL THROMBOSIS 2 0.0010
254 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
255 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
256 PROSTATOMEGALY 4 0.0010
257 ARTERIAL OCCLUSIVE DISEASE 8 0.0010
258 STAPHYLOCOCCAL SEPSIS 5 0.0010
259 URINE ANALYSIS ABNORMAL 3 0.0010
260 ASPHYXIA 8 0.0010
261 FIBROSIS 3 0.0010
262 GRAFT VERSUS HOST DISEASE 7 0.0010
263 PERIPHERAL VASCULAR DISORDER 5 0.0010
264 HYPERPARATHYROIDISM 2 0.0010
265 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
266 BLOOD BLISTER 3 0.0010
267 AORTIC VALVE INCOMPETENCE 4 0.0009
268 C-REACTIVE PROTEIN INCREASED 34 0.0009
269 THROMBOTIC MICROANGIOPATHY 9 0.0009
270 CARDIAC FAILURE 74 0.0009
271 HENOCH-SCHONLEIN PURPURA 2 0.0009
272 DEAFNESS NEUROSENSORY 3 0.0009
273 PULMONARY HAEMORRHAGE 7 0.0009
274 CEREBRAL HAEMATOMA 3 0.0009
275 MULTIPLE USE OF SINGLE-USE PRODUCT 5 0.0009
276 NEOPLASM RECURRENCE 3 0.0009
277 PRODUCT LABEL ISSUE 6 0.0009
278 DRUG EFFECT DELAYED 4 0.0009
279 ECCHYMOSIS 6 0.0009
280 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
281 THROMBOPHLEBITIS 3 0.0009
282 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
283 HAEMORRHAGIC DIATHESIS 3 0.0008
284 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
285 DIABETES INSIPIDUS 2 0.0008
286 STILLBIRTH 4 0.0008
287 WRONG TECHNIQUE IN DRUG USAGE PROCESS 30 0.0008
288 DIZZINESS POSTURAL 8 0.0008
289 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
290 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 5 0.0008
291 HAEMOGLOBIN DECREASED 83 0.0008
292 VEIN DISORDER 4 0.0008
293 DRUG EFFECT INCOMPLETE 29 0.0008
294 GROIN PAIN 7 0.0008
295 PROTEIN TOTAL DECREASED 3 0.0008
296 RESPIRATORY RATE INCREASED 7 0.0008
297 MOTOR DYSFUNCTION 8 0.0008
298 ISCHAEMIC STROKE 14 0.0008
299 DEVICE MALFUNCTION 55 0.0008
300 DISSEMINATED TUBERCULOSIS 2 0.0008
301 PROCTALGIA 5 0.0008
302 MULTIPLE ORGAN DYSFUNCTION SYNDROME 22 0.0008
303 ATRIOVENTRICULAR BLOCK 6 0.0008
304 DRUG TITRATION ERROR 2 0.0008
305 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
306 ACTINIC KERATOSIS 2 0.0008
307 HEPATITIS TOXIC 2 0.0008
308 COMPARTMENT SYNDROME 2 0.0008
309 VENOUS THROMBOSIS 3 0.0008
310 PRODUCT PREPARATION ISSUE 5 0.0008
311 PNEUMONIA FUNGAL 3 0.0008
312 PULMONARY CONGESTION 10 0.0008
313 PRODUCT PRESCRIBING ERROR 18 0.0008
314 HEPATIC FUNCTION ABNORMAL 28 0.0007
315 ANAESTHETIC COMPLICATION 2 0.0007
316 DRUG EFFECT LESS THAN EXPECTED 11 0.0007
317 HYPOKALAEMIA 34 0.0007
318 BLOOD PHOSPHORUS INCREASED 2 0.0007
319 DEVICE MECHANICAL ISSUE 10 0.0007
320 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
321 COAGULOPATHY 12 0.0007
322 POOR PERIPHERAL CIRCULATION 3 0.0007
323 CARDIAC FAILURE CHRONIC 3 0.0007
324 HAEMATOLOGICAL MALIGNANCY 2 0.0007
325 DUODENAL ULCER HAEMORRHAGE 2 0.0007
326 SHOCK 16 0.0007
327 MYOPATHY 6 0.0007
328 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
329 INJECTION SITE HAEMATOMA 10 0.0007
330 URINE OUTPUT DECREASED 6 0.0007
331 PRODUCT LABEL CONFUSION 4 0.0007
332 PRODUCT QUALITY ISSUE 92 0.0007
333 POST PROCEDURAL COMPLICATION 13 0.0007
334 MEDICAL DEVICE COMPLICATION 5 0.0007
335 HEPATITIS FULMINANT 2 0.0007
336 VENTRICULAR EXTRASYSTOLES 7 0.0007
337 ATAXIA 8 0.0007
338 DRUG INEFFECTIVE 888 0.0007
339 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
340 MALIGNANT MELANOMA 9 0.0007
341 BRAIN HERNIATION 2 0.0007
342 HYDRONEPHROSIS 5 0.0007
343 INJECTION SITE DISCOMFORT 7 0.0007
344 SUSPECTED OFF LABEL USE 3 0.0007
345 CYTOMEGALOVIRUS INFECTION 11 0.0007
346 PATHOGEN RESISTANCE 6 0.0007
347 ABDOMINAL HERNIA 3 0.0007
348 HAEMODYNAMIC INSTABILITY 5 0.0007
349 PHARMACEUTICAL PRODUCT COMPLAINT 17 0.0007
350 DYSPAREUNIA 3 0.0007
351 DYSAESTHESIA 2 0.0007
352 INTRACARDIAC THROMBUS 2 0.0007
353 ECTOPIC PREGNANCY 2 0.0006
354 PREGNANCY 13 0.0006
355 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
356 BRAIN DEATH 2 0.0006
357 MULTIPLE MYELOMA 3 0.0006
358 GASTRITIS EROSIVE 3 0.0006
359 ALANINE AMINOTRANSFERASE INCREASED 39 0.0006
360 DIALYSIS 9 0.0006
361 VENTRICULAR FIBRILLATION 7 0.0006
362 RENAL CYST 5 0.0006
363 BLOOD CREATININE INCREASED 41 0.0006
364 HYPOVOLAEMIC SHOCK 3 0.0006
365 PULMONARY OEDEMA 28 0.0006
366 TRANSPLANT REJECTION 5 0.0006
367 BACTERIAL SEPSIS 2 0.0006
368 ASCITES 18 0.0006
369 INCORRECT PRODUCT STORAGE 8 0.0006
370 DRUG-INDUCED LIVER INJURY 19 0.0006
371 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 2 0.0006
372 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
373 END STAGE RENAL DISEASE 11 0.0006
374 BLOOD CHOLESTEROL INCREASED 28 0.0006
375 CARDIAC FAILURE ACUTE 4 0.0006
376 DRUG TOLERANCE 3 0.0006
377 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
378 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
379 DRUG DISPENSING ERROR 9 0.0006
380 DRUG ADMINISTRATION ERROR 18 0.0006
381 CARDIAC OPERATION 5 0.0006
382 LEFT VENTRICULAR FAILURE 2 0.0006
383 SKIN ULCER 15 0.0006
384 BLOOD URINE PRESENT 11 0.0006
385 AORTIC STENOSIS 2 0.0006
386 NO THERAPEUTIC RESPONSE 7 0.0006
387 CAROTID ARTERY STENOSIS 2 0.0006
388 CYANOSIS 9 0.0006
389 IMMUNOSUPPRESSION 5 0.0006
390 PRODUCT COMMUNICATION ISSUE 5 0.0006
391 PREMATURE BABY 17 0.0006
392 FIBRIN D DIMER INCREASED 2 0.0006
393 FRUSTRATION 2 0.0006
394 MYOSITIS 5 0.0006
395 BLOOD BILIRUBIN INCREASED 15 0.0006
396 HAEMATURIA 19 0.0006
397 BLOOD POTASSIUM INCREASED 9 0.0006
398 PRODUCT DISPENSING ERROR 12 0.0006
399 CAROTID ARTERY OCCLUSION 2 0.0005
400 INTESTINAL ISCHAEMIA 3 0.0005
401 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
402 IRON DEFICIENCY ANAEMIA 5 0.0005
403 HEPATIC CANCER STAGE IV 2 0.0005
404 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
405 CANDIDA INFECTION 9 0.0005
406 PEMPHIGOID 4 0.0005
407 PRODUCT PACKAGING ISSUE 5 0.0005
408 MULTI-ORGAN FAILURE 9 0.0005
409 DRUG PRESCRIBING ERROR 10 0.0005
410 BLOOD URIC ACID INCREASED 3 0.0005
411 DEVICE DEFECTIVE 9 0.0005
412 RALES 3 0.0005
413 DYSURIA 19 0.0005
414 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
415 DIABETES MELLITUS 39 0.0005
416 PLEURAL EFFUSION 31 0.0005
417 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 36 0.0005
418 TRICUSPID VALVE INCOMPETENCE 4 0.0005
419 HAEMOPTYSIS 14 0.0005
420 POOR QUALITY DEVICE USED 5 0.0005
421 HEPATITIS B 3 0.0005
422 SENSORY LOSS 4 0.0005
423 TOXIC SKIN ERUPTION 5 0.0005
424 GALLBLADDER OPERATION 2 0.0005
425 VULVOVAGINAL BURNING SENSATION 3 0.0005
426 CEREBRAL INFARCTION 12 0.0005
427 SUBARACHNOID HAEMORRHAGE 5 0.0005
428 BODY TEMPERATURE INCREASED 10 0.0005
429 HICCUPS 4 0.0005
430 ANAPHYLACTOID REACTION 2 0.0005
431 VENTRICULAR TACHYCARDIA 8 0.0005
432 ACUTE CORONARY SYNDROME 4 0.0005
433 EXPIRED PRODUCT ADMINISTERED 16 0.0005
434 INJECTION SITE DISCOLOURATION 6 0.0005
435 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
436 CONGESTIVE CARDIOMYOPATHY 2 0.0005
437 INTENTIONAL DRUG MISUSE 10 0.0005
438 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
439 DRUG ADMINISTERED AT INAPPROPRIATE SITE 5 0.0005
440 HAEMORRHAGE INTRACRANIAL 7 0.0005
441 DEVICE BREAKAGE 19 0.0005
442 PRODUCT CONTAINER ISSUE 4 0.0005
443 ANURIA 4 0.0005
444 ANGINA UNSTABLE 3 0.0005
445 WOUND INFECTION 5 0.0005
446 INJECTION SITE HAEMORRHAGE 36 0.0005
447 ILEUS PARALYTIC 2 0.0004
448 PROSTATE CANCER 36 0.0004
449 HAEMOLYTIC ANAEMIA 4 0.0004
450 PRODUCT ADMINISTRATION ERROR 9 0.0004
451 LOSS OF LIBIDO 4 0.0004
452 PRODUCT USE COMPLAINT 7 0.0004
453 POSTOPERATIVE WOUND INFECTION 3 0.0004
454 WRONG PRODUCT ADMINISTERED 3 0.0004
455 ABSCESS 7 0.0004
456 HAEMOGLOBIN INCREASED 2 0.0004
457 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
458 HAIR GROWTH ABNORMAL 3 0.0004
459 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
460 EXTRASYSTOLES 3 0.0004
461 CORONARY ARTERY DISEASE 13 0.0004
462 FEELING OF DESPAIR 2 0.0004
463 BACTERIAL INFECTION 8 0.0004
464 DUODENAL ULCER 3 0.0004
465 FEAR OF INJECTION 3 0.0004
466 INCORRECT DOSE ADMINISTERED BY DEVICE 11 0.0004
467 ANGINA PECTORIS 12 0.0004
468 VISUAL FIELD DEFECT 3 0.0004
469 DEVICE LEAKAGE 18 0.0004
470 TONGUE DISORDER 3 0.0004
471 ATELECTASIS 4 0.0004
472 NOCTURIA 5 0.0004
473 HORMONE LEVEL ABNORMAL 2 0.0004
474 OXYGEN SATURATION DECREASED 23 0.0004
475 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
476 BODY TEMPERATURE DECREASED 4 0.0004
477 STEVENS-JOHNSON SYNDROME 9 0.0004
478 PLATELET COUNT DECREASED 43 0.0004
479 HAEMATOCRIT DECREASED 8 0.0004
480 ANEURYSM 2 0.0004
481 INJECTION SITE INFLAMMATION 2 0.0004
482 DEVICE USE ISSUE 7 0.0004
483 CORONARY ARTERY STENOSIS 2 0.0004
484 TROPONIN INCREASED 3 0.0004
485 AORTIC ANEURYSM 3 0.0004
486 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
487 PROCEDURAL COMPLICATION 3 0.0004
488 URINARY RETENTION 13 0.0004
489 PRODUCT PREPARATION ERROR 8 0.0004
490 HYPERBILIRUBINAEMIA 4 0.0004
491 TENDERNESS 4 0.0004
492 LIVER DISORDER 17 0.0004
493 ARRHYTHMIA 18 0.0004
494 BLOOD LACTATE DEHYDROGENASE INCREASED 6 0.0004
495 INTERSTITIAL LUNG DISEASE 18 0.0004
496 FRUSTRATION TOLERANCE DECREASED 3 0.0004
497 ANAL ABSCESS 2 0.0004
498 DECUBITUS ULCER 3 0.0004
499 OESOPHAGITIS 4 0.0004
500 ESCHERICHIA INFECTION 3 0.0004
501 DEAFNESS UNILATERAL 2 0.0004
502 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
503 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
504 THERAPY NON-RESPONDER 16 0.0004
505 PANCREATITIS ACUTE 8 0.0004
506 DEVICE OCCLUSION 5 0.0004
507 MITRAL VALVE INCOMPETENCE 4 0.0004
508 CHOLECYSTITIS ACUTE 2 0.0004
509 DRUG EXPOSURE DURING PREGNANCY 12 0.0004
510 GENERALISED ERYTHEMA 2 0.0004
511 MICTURITION URGENCY 4 0.0003
512 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
513 PARALYSIS 5 0.0003
514 CARDIOGENIC SHOCK 5 0.0003
515 GASTRIC HAEMORRHAGE 4 0.0003
516 HAEMATOMA 9 0.0003
517 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
518 CARDIAC MURMUR 3 0.0003
519 BLOOD PRESSURE DECREASED 23 0.0003
520 BLOOD GLUCOSE INCREASED 65 0.0003
521 SEPTIC SHOCK 15 0.0003
522 MEDICATION ERROR 19 0.0003
523 LUNG INFILTRATION 3 0.0003
524 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
525 CARDIOMYOPATHY 5 0.0003
526 PERITONITIS 7 0.0003
527 CATARACT OPERATION 2 0.0003
528 PULMONARY HYPERTENSION 7 0.0003
529 OSTEOPENIA 5 0.0003
530 FOETAL GROWTH RESTRICTION 2 0.0003
531 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 18 0.0003
532 EPILEPSY 10 0.0003
533 PNEUMONIA BACTERIAL 3 0.0003
534 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
535 CARDIOMEGALY 4 0.0003
536 LYMPHOMA 5 0.0003
537 EJECTION FRACTION DECREASED 5 0.0003
538 INFUSION SITE EXTRAVASATION 2 0.0003
539 SPUTUM DISCOLOURED 3 0.0003
540 MUSCLE ATROPHY 4 0.0003
541 PROTEINURIA 6 0.0003
542 PNEUMOTHORAX 5 0.0003
543 DRUG INTERACTION 50 0.0003
544 RED BLOOD CELL COUNT DECREASED 9 0.0003
545 ANAEMIA 60 0.0003
546 ULCER 5 0.0003
547 ENTERITIS 2 0.0003
548 ANOREXIA 4 0.0003
549 ANAPHYLACTIC SHOCK 8 0.0003
550 HAEMORRHOIDS 6 0.0003
551 FUNGAL INFECTION 10 0.0003
552 INJECTION SITE PAIN 92 0.0003
553 DISCOMFORT 18 0.0003
554 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
555 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
556 PERIPHERAL COLDNESS 4 0.0003
557 MUSCULOSKELETAL DISCOMFORT 5 0.0003
558 NEURALGIA 7 0.0003
559 FORMICATION 2 0.0003
560 MASS 4 0.0003
561 NEUROTOXICITY 5 0.0003
562 SUDDEN DEATH 3 0.0003
563 INTERNATIONAL NORMALISED RATIO INCREASED 8 0.0003
564 BODY HEIGHT DECREASED 3 0.0003
565 LEUKOPENIA 14 0.0003
566 CEREBRAL HAEMORRHAGE 10 0.0003
567 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13 0.0003
568 CARDIOVASCULAR DISORDER 7 0.0003
569 LIVER FUNCTION TEST ABNORMAL 8 0.0003
570 RESPIRATORY FAILURE 20 0.0003
571 GASTROENTERITIS 4 0.0003
572 BLOOD GLUCOSE FLUCTUATION 3 0.0003
573 CHEST DISCOMFORT 28 0.0003
574 STAPHYLOCOCCAL INFECTION 9 0.0003
575 DRUG RESISTANCE 7 0.0003
576 ACUTE MYOCARDIAL INFARCTION 8 0.0003
577 CEREBRAL DISORDER 2 0.0003
578 NERVE INJURY 3 0.0003
579 ATRIAL FIBRILLATION 26 0.0003
580 BLOOD CALCIUM DECREASED 3 0.0003
581 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
582 BRADYCARDIA 14 0.0003
583 CHRONIC KIDNEY DISEASE 20 0.0003
584 MYOCARDITIS 3 0.0003
585 ACIDOSIS 2 0.0003
586 DEVICE RELATED INFECTION 4 0.0003
587 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
588 HAEMOLYSIS 2 0.0003
589 ELECTROLYTE IMBALANCE 3 0.0003
590 VASCULITIS 3 0.0003
591 HYPOACUSIS 11 0.0003
592 RESPIRATORY ARREST 7 0.0003
593 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
594 BLOOD PRESSURE ABNORMAL 5 0.0003
595 PYREXIA 87 0.0003
596 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
597 SEPSIS 28 0.0003
598 ATRIAL FLUTTER 2 0.0003
599 METABOLIC ACIDOSIS 8 0.0002
600 RENAL IMPAIRMENT 21 0.0002
601 HEPATIC ENZYME INCREASED 17 0.0002
602 BURSITIS 3 0.0002
603 BONE MARROW FAILURE 5 0.0002
604 LUNG DISORDER 12 0.0002
605 PHARYNGITIS 3 0.0002
606 WHITE BLOOD CELL COUNT DECREASED 26 0.0002
607 CELLULITIS 12 0.0002
608 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
609 BRAIN OEDEMA 3 0.0002
610 FACE OEDEMA 4 0.0002
611 URINARY INCONTINENCE 7 0.0002
612 RENAL INJURY 7 0.0002
613 INTRAOCULAR PRESSURE INCREASED 3 0.0002
614 MYDRIASIS 3 0.0002
615 SCAR 4 0.0002
616 HEPATIC FAILURE 7 0.0002
617 INJECTION SITE INDURATION 3 0.0002
618 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
619 DELIRIUM 8 0.0002
620 CONDITION AGGRAVATED 70 0.0002
621 PLATELET COUNT INCREASED 3 0.0002
622 HAEMORRHAGE 24 0.0002
623 BLOOD CALCIUM INCREASED 2 0.0002
624 GASTRITIS 6 0.0002
625 GRIP STRENGTH DECREASED 2 0.0002
626 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 46 0.0002
627 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
628 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
629 ANAL INCONTINENCE 2 0.0002
630 ABDOMINAL DISTENSION 23 0.0002
631 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
632 INCORRECT DOSE ADMINISTERED 50 0.0002
633 EXOSTOSIS 2 0.0002
634 RENAL FAILURE 29 0.0002
635 SKIN DISCOLOURATION 10 0.0002
636 RESPIRATORY DISTRESS 6 0.0002
637 URINARY TRACT INFECTION 37 0.0002
638 GRAND MAL CONVULSION 2 0.0002
639 PERICARDIAL EFFUSION 5 0.0002
640 AGRANULOCYTOSIS 4 0.0002
641 ERYTHEMA MULTIFORME 2 0.0002
642 APPENDICITIS 2 0.0002
643 BLOOD SODIUM DECREASED 4 0.0002
644 RENAL FAILURE ACUTE 9 0.0002
645 MUSCULOSKELETAL PAIN 11 0.0002
646 SYNCOPE 21 0.0002
647 EYE INFLAMMATION 2 0.0002
648 PRODUCTIVE COUGH 10 0.0002
649 DIABETIC KETOACIDOSIS 5 0.0002
650 GLAUCOMA 4 0.0002
651 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
652 HYPERCHOLESTEROLAEMIA 2 0.0002
653 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
654 DYSTONIA 4 0.0002
655 PRESYNCOPE 5 0.0002
656 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
657 HEPATOMEGALY 2 0.0002
658 KNEE OPERATION 2 0.0002
659 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
660 DISORIENTATION 8 0.0002
661 BLADDER DISORDER 2 0.0002
662 MYOCARDIAL INFARCTION 35 0.0002
663 HYPOTONIA 2 0.0002
664 DEEP VEIN THROMBOSIS 13 0.0002
665 BRAIN INJURY 2 0.0002
666 HEART RATE DECREASED 7 0.0002
667 CARDIAC FAILURE CONGESTIVE 16 0.0002
668 HAEMATEMESIS 5 0.0002
669 PRODUCT USE ISSUE 37 0.0002
670 BLINDNESS 8 0.0002
671 HEPATITIS 5 0.0002
672 HYPOTENSION 39 0.0002
673 MYELOSUPPRESSION 7 0.0002
674 CARDIAC ARREST 16 0.0002
675 UNRESPONSIVE TO STIMULI 5 0.0002
676 INFECTION 28 0.0002
677 EYE DISCHARGE 2 0.0002
678 THERAPY PARTIAL RESPONDER 3 0.0002
679 RHABDOMYOLYSIS 8 0.0002
680 POLLAKIURIA 8 0.0002
681 FOLLICULITIS 2 0.0002
682 ANHEDONIA 5 0.0002
683 DEVICE ISSUE 17 0.0002
684 HALLUCINATION, VISUAL 4 0.0002
685 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
686 RASH ERYTHEMATOUS 9 0.0002
687 LOSS OF CONSCIOUSNESS 24 0.0002
688 NIGHT SWEATS 6 0.0002
689 FEAR 5 0.0002
690 VISUAL IMPAIRMENT 23 0.0002
691 DECREASED ACTIVITY 2 0.0002
692 HYPERTENSION 39 0.0002
693 OFF LABEL USE 161 0.0002
694 CEREBROVASCULAR ACCIDENT 31 0.0002
695 PRODUCT STORAGE ERROR 16 0.0002
696 PHOTOSENSITIVITY REACTION 3 0.0002
697 APPLICATION SITE PAIN 4 0.0002
698 STOMATITIS 11 0.0002
699 TRANSAMINASES INCREASED 4 0.0002
700 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
701 WOUND 5 0.0002
702 GASTROINTESTINAL DISORDER 16 0.0002
703 FISTULA 2 0.0002
704 TARDIVE DYSKINESIA 5 0.0002
705 CONTUSION 17 0.0002
706 CHOLECYSTECTOMY 2 0.0002
707 CONVULSION 10 0.0002
708 ORTHOSTATIC HYPOTENSION 3 0.0002
709 EYELID OEDEMA 2 0.0002
710 RENAL DISORDER 8 0.0002
711 INTENTIONAL PRODUCT MISUSE 15 0.0002
712 BURNING SENSATION 12 0.0002
713 HYPERKALAEMIA 6 0.0002
714 HYPOXIA 6 0.0002
715 LABORATORY TEST ABNORMAL 5 0.0002
716 BACTERAEMIA 2 0.0002
717 PULMONARY EMBOLISM 16 0.0002
718 GALLBLADDER DISORDER 3 0.0002
719 ACCIDENT 2 0.0002
720 CARDIO-RESPIRATORY ARREST 7 0.0002
721 RESPIRATORY DISORDER 5 0.0002
722 BLOOD POTASSIUM DECREASED 5 0.0002
723 HYPOGLYCAEMIA 8 0.0002
724 NEOPLASM MALIGNANT 11 0.0002
725 BONE DISORDER 3 0.0002
726 CYTOPENIA 2 0.0002
727 HAEMATOCHEZIA 9 0.0002
728 ENCEPHALOPATHY 4 0.0002
729 INJECTION SITE MASS 6 0.0002
730 INJECTION SITE EXTRAVASATION 2 0.0002
731 CHILLS 19 0.0002
732 ABASIA 4 0.0002
733 THROMBOSIS 13 0.0002
734 HEART RATE INCREASED 16 0.0002
735 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
736 CYST 2 0.0002
737 MENTAL DISORDER 7 0.0002
738 PNEUMONIA 52 0.0002
739 BLISTER 9 0.0002
740 PNEUMONIA ASPIRATION 4 0.0002
741 HYPONATRAEMIA 9 0.0002
742 INTESTINAL OBSTRUCTION 6 0.0002
743 PRODUCT COMPLAINT 4 0.0002
744 GASTRIC ULCER 3 0.0002
745 INJECTION SITE IRRITATION 2 0.0002
746 HERPES ZOSTER 9 0.0002
747 PULMONARY FIBROSIS 3 0.0002
748 SEIZURE 18 0.0002
749 HIATUS HERNIA 2 0.0002
750 EXPOSURE VIA SKIN CONTACT 4 0.0002
751 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
752 AMNESIA 10 0.0002
753 PALPITATIONS 18 0.0002
754 KIDNEY INFECTION 3 0.0002
755 BLADDER CANCER 9 0.0002
756 TINNITUS 7 0.0002
757 THROMBOCYTOPENIA 17 0.0002
758 DEPRESSED MOOD 8 0.0002
759 CATARACT 9 0.0002
760 UNDERDOSE 11 0.0002
761 UPPER LIMB FRACTURE 3 0.0002
762 BLOOD PRESSURE INCREASED 23 0.0002
763 PRESCRIBED UNDERDOSE 3 0.0002
764 PRODUCT PHYSICAL ISSUE 3 0.0001
765 TYPE 2 DIABETES MELLITUS 5 0.0001
766 THERAPEUTIC RESPONSE DECREASED 9 0.0001
767 OEDEMA 8 0.0001
768 LIMB INJURY 4 0.0001
769 NEUTROPHIL COUNT DECREASED 6 0.0001
770 DRUG TOXICITY 2 0.0001
771 IMPAIRED GASTRIC EMPTYING 2 0.0001
772 MOOD ALTERED 4 0.0001
773 CORONARY ARTERY OCCLUSION 2 0.0001
774 BLOOD GLUCOSE DECREASED 7 0.0001
775 PANCYTOPENIA 8 0.0001
776 CARPAL TUNNEL SYNDROME 2 0.0001
777 MOUTH ULCERATION 3 0.0001
778 BLINDNESS UNILATERAL 2 0.0001
779 HYPOAESTHESIA 21 0.0001
780 BRONCHOSPASM 2 0.0001
781 OEDEMA PERIPHERAL 17 0.0001
782 SKIN CANCER 3 0.0001
783 PRODUCT PRESCRIBING ISSUE 3 0.0001
784 ACCIDENTAL OVERDOSE 5 0.0001
785 RESTLESSNESS 5 0.0001
786 DEPRESSION 31 0.0001
787 OVERDOSE 29 0.0001
788 ORAL PAIN 3 0.0001
789 RASH PAPULAR 3 0.0001
790 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
791 PAIN 82 0.0001
792 HYPOAESTHESIA ORAL 2 0.0001
793 ECONOMIC PROBLEM 2 0.0001
794 COLITIS 5 0.0001
795 FEELING HOT 8 0.0001
796 CHEST PAIN 24 0.0001
797 GYNAECOMASTIA 4 0.0001
798 INJURY 9 0.0001
799 FLUSHING 13 0.0001
800 BONE DENSITY DECREASED 4 0.0001
801 COMA 6 0.0001
802 PAIN IN EXTREMITY 37 0.0001
803 BLOOD PRESSURE FLUCTUATION 3 0.0001
804 HYPERSENSITIVITY 23 0.0001
805 TACHYCARDIA 11 0.0001
806 MUSCULAR WEAKNESS 14 0.0001
807 IMPAIRED HEALING 4 0.0001
808 EYE DISORDER 4 0.0001
809 DRUG LEVEL INCREASED 2 0.0001
810 VISUAL ACUITY REDUCED 4 0.0001
811 LIP SWELLING 4 0.0001
812 SKIN DISORDER 4 0.0001
813 HOT FLUSH 9 0.0001
814 DIARRHOEA 77 0.0001
815 ANGER 4 0.0001
816 HEMIPARESIS 2 0.0001
817 CONFUSIONAL STATE 19 0.0001
818 SWELLING 11 0.0001
819 INFLAMMATION 6 0.0001
820 RASH GENERALISED 3 0.0001
821 DEVICE USE ERROR 4 0.0001
822 VERTIGO 7 0.0001
823 JOINT STIFFNESS 3 0.0001
824 EOSINOPHILIA 2 0.0001
825 SLEEP DISORDER 8 0.0001
826 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
827 DRUG ERUPTION 2 0.0001
828 BACK PAIN 26 0.0001
829 JAUNDICE 3 0.0001
830 PNEUMONITIS 3 0.0001
831 TREATMENT NONCOMPLIANCE 6 0.0001
832 FEELING COLD 3 0.0001
833 EPISTAXIS 8 0.0001
834 HEPATIC CIRRHOSIS 2 0.0001
835 DYSPNOEA EXERTIONAL 4 0.0001
836 DEVICE DIFFICULT TO USE 7 0.0001
837 HYPOCALCAEMIA 2 0.0001
838 FRACTURE 2 0.0001
839 FOOT FRACTURE 2 0.0001
840 ANXIETY 30 0.0001
841 MULTIPLE SCLEROSIS 5 0.0001
842 ACUTE KIDNEY INJURY 16 0.0001
843 ACUTE RESPIRATORY FAILURE 2 0.0001
844 MUSCLE SPASMS 19 0.0001
845 ERUCTATION 2 0.0001
846 NEUTROPENIA 14 0.0001
847 ERYTHEMA 21 0.0001
848 WHEEZING 6 0.0001
849 CONSTIPATION 22 0.0001
850 INJECTION SITE BRUISING 8 0.0001
851 CYTOKINE RELEASE SYNDROME 2 0.0001
852 APHASIA 3 0.0001
853 LUNG NEOPLASM MALIGNANT 4 0.0001
854 OSTEOPOROSIS 4 0.0001
855 FEMUR FRACTURE 3 0.0001
856 TREMOR 16 0.0001
857 CARDIAC DISORDER 9 0.0001
858 NERVOUSNESS 5 0.0001
859 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
860 HEAD INJURY 3 0.0001
861 MEMORY IMPAIRMENT 13 0.0001
862 MOVEMENT DISORDER 3 0.0001
863 LIVER FUNCTION TEST INCREASED 2 0.0001
864 HYPERHIDROSIS 12 0.0001
865 LACTIC ACIDOSIS 3 0.0001
866 UNEVALUABLE EVENT 7 0.0001
867 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
868 FAECES DISCOLOURED 2 0.0001
869 DIZZINESS 46 0.0001
870 VOMITING 43 0.0001
871 OSTEONECROSIS 3 0.0001
872 EMOTIONAL DISTRESS 11 0.0001
873 VIRAL INFECTION 3 0.0001
874 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
875 GLOSSODYNIA 2 0.0001
876 ARTHRITIS 7 0.0001
877 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
878 CHROMATURIA 2 0.0001
879 SUICIDAL IDEATION 8 0.0001
880 COUGH 24 0.0001
881 SURGERY 5 0.0001
882 NASAL CONGESTION 5 0.0001
883 LYMPHADENOPATHY 3 0.0001
884 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
885 DISEASE PROGRESSION 10 0.0001
886 NEUROPATHY PERIPHERAL 8 0.0001
887 DISEASE RECURRENCE 4 0.0001
888 IRRITABILITY 5 0.0001
889 PARAESTHESIA 13 0.0001
890 HYPERGLYCAEMIA 3 0.0001
891 LIVER INJURY 2 0.0001
892 HEADACHE 51 0.0001
893 DRUG DEPENDENCE 13 0.0001
894 EXPOSURE DURING PREGNANCY 5 0.0001
895 AGEUSIA 2 0.0001
896 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
897 ABDOMINAL PAIN LOWER 2 0.0001
898 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
899 RHINORRHOEA 5 0.0001
900 SWELLING FACE 5 0.0001
901 MYALGIA 13 0.0001
902 DYSPNOEA 43 0.0001
903 ABNORMAL BEHAVIOUR 3 0.0001
904 ABORTION SPONTANEOUS 3 0.0001
905 ASTHENIA 28 0.0001
906 DISTURBANCE IN ATTENTION 4 0.0001
907 DYSKINESIA 3 0.0001
908 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
909 RASH PRURITIC 4 0.0001
910 ABNORMAL DREAMS 2 0.0001
911 DIVERTICULITIS 2 0.0001
912 FALL 24 0.0001
913 NECK PAIN 4 0.0001
914 INSOMNIA 19 0.0001
915 RECTAL HAEMORRHAGE 3 0.0001
916 DYSSTASIA 2 0.0001
917 ANGIOEDEMA 3 0.0001
918 BRONCHITIS 5 0.0001
919 THROAT IRRITATION 3 0.0001
920 ADVERSE DRUG REACTION 6 0.0001
921 NO ADVERSE EVENT 12 0.0001
922 MALAISE 29 0.0001
923 PERIPHERAL SWELLING 10 0.0001
924 EMOTIONAL DISORDER 2 0.0001
925 OROPHARYNGEAL PAIN 6 0.0001
926 INJECTION SITE ERYTHEMA 8 0.0001
927 DRUG DOSE OMISSION BY DEVICE 5 0.0001
928 GAIT DISTURBANCE 12 0.0001
929 PRURITUS 24 0.0001
930 RASH 27 0.0001
931 DYSPEPSIA 6 0.0001
932 TREATMENT FAILURE 5 0.0001
933 INFUSION RELATED REACTION 4 0.0001
934 FEBRILE NEUTROPENIA 4 0.0001
935 DRY EYE 3 0.0001
936 AGGRESSION 3 0.0001
937 ABDOMINAL PAIN UPPER 12 0.0001
938 GASTRIC DISORDER 2 0.0001
939 VISION BLURRED 8 0.0001
940 WEIGHT INCREASED 13 0.0001
941 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
942 SPEECH DISORDER 3 0.0001
943 PANCREATITIS 3 0.0001
944 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
945 NAUSEA 44 0.0001
946 DEPENDENCE 3 0.0001
947 FEELING ABNORMAL 13 0.0001
948 DYSGEUSIA 4 0.0001
949 INFLUENZA 6 0.0001
950 WEIGHT DECREASED 15 0.0001
951 FLATULENCE 3 0.0001
952 INJECTION SITE SWELLING 4 0.0001
953 ABDOMINAL PAIN 12 0.0001
954 COVID-19 9 0.0001
955 BONE PAIN 3 0.0001
956 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
957 SUICIDE ATTEMPT 3 0.0000
958 SINUSITIS 5 0.0000
959 ARTHRALGIA 20 0.0000
960 URTICARIA 8 0.0000
961 DECREASED APPETITE 11 0.0000
962 DEHYDRATION 6 0.0000
963 COLITIS ULCERATIVE 2 0.0000
964 SOMNOLENCE 9 0.0000
965 DEATH 38 0.0000
966 NASOPHARYNGITIS 8 0.0000
967 MIGRAINE 4 0.0000
968 MOBILITY DECREASED 3 0.0000
969 ABDOMINAL DISCOMFORT 7 0.0000
970 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
971 DRUG INTOLERANCE 4 0.0000
972 AGITATION 3 0.0000
973 FATIGUE 31 0.0000
974 FLUID RETENTION 2 0.0000
975 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
976 ILLNESS 4 0.0000
977 ECZEMA 2 0.0000
978 DRUG ABUSE 3 0.0000
979 ARTHROPATHY 2 0.0000
980 EYE PAIN 2 0.0000
981 EYE IRRITATION 2 0.0000
982 ILL-DEFINED DISORDER 2 0.0000
983 BALANCE DISORDER 2 0.0000
984 DYSPHAGIA 2 0.0000
985 PRODUCT DOSE OMISSION ISSUE 6 0.0000
986 DRUG DOSE OMISSION 3 0.0000
987 TOXICITY TO VARIOUS AGENTS 3 0.0000
988 ASTHMA 2 0.0000
989 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
990 JOINT SWELLING 2 0.0000
991 ALOPECIA 3 0.0000
992 HOSPITALISATION 2 0.0000